Statins exhibit an anti-tumor effect by attenuating PD-L1 in breast cancer cells and macrophages and reducing breast tumor progression in xenograft mouse model

被引：0
|
作者：
Lee, Sangeun
Kim, Hoe Suk
Yoon, So-Hyun
Ryu, Seungyeon
Baek, Moonjou
Park, A. Young
Lee, Han-Byoel
Han, Wonshik
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 05期
关键词：
D O I：
10.1158/1538-7445.SABCS22-P2-26-10
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2-26-10
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Targeting NKT cells and PD-L1 pathway results in augmented anti-tumor responses in a melanoma model
    Durgan, Kevin
    Ali, Mohamed
    Warner, Paul
    Latchman, Yvette E.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2011, 60 (04) : 547 - 558
  • [42] PD-L1 expression on circulating epithelial tumor cells (CETCs) is associated with immune evasion and tumor progression in breast cancer patients and differs from PD-L2 expression
    Lux, D.
    CLINICAL & EXPERIMENTAL METASTASIS, 2018, 35 (03) : 198 - 198
  • [43] GSDMD is associated with survival in human breast cancer but does not impact anti-tumor immunity in a mouse breast cancer model
    Boersma, Bart
    Puddinu, Viola
    Huard, Arnaud
    Fauteux-Daniel, Sebastien
    Wirapati, Pratyaksha
    Guedri, Sofia
    Tille, Jean-Christophe
    Mckee, Thomas
    Pittet, Mikael
    Palmer, Gaby
    Bourquin, Carole
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [44] A Novel Chimeric Poxvirus Encoding an Anti-PD-L1 Protein Shows Safety and Anti-Tumor Activity in Breast Cancer Model
    Chaurasiya, Shyambabu
    Lu, Jianming
    Kim, Sang-In
    Warner, Susanne G.
    Woo, Yanghee
    Chen, Nanhai G.
    Fong, Yuman
    MOLECULAR THERAPY, 2019, 27 (04) : 192 - 192
  • [45] BET protein targeting suppresses the PD-1/PD-L1 pathway in triple-negative breast cancer and elicits anti-tumor immune response
    Andrieu, Guillaume P.
    Shafran, Jordan S.
    Smith, Charlotte L.
    Belkina, Anna C.
    Casey, Allison N.
    Jafari, Naser
    Denis, Gerald V.
    CANCER LETTERS, 2019, 465 : 45 - 58
  • [46] BET bromodomain targeting suppresses the PD-1/PD-L1 pathway in triple-negative breast cancer and elicits anti-tumor immune response
    Andrieu, Guillaume
    Shafran, Jordan S.
    Denis, Gerald V.
    JOURNAL OF IMMUNOLOGY, 2019, 202 (01):
  • [47] Non-invasive immunoPET imaging of PD-L1 using anti-PD-L1-B11 in breast cancer and melanoma tumor model
    Bansal, Aditya
    Pandey, Mukesh K.
    Barham, Whitney
    Liu, Xin
    Harrington, Susan M.
    Lucien, Fabrice
    Dong, Haidong
    Park, Sean S.
    DeGrado, Timothy R.
    NUCLEAR MEDICINE AND BIOLOGY, 2021, 100 : 4 - 11
  • [48] Honokiol suppress the PD-L1 expression to improve anti-tumor immunity in lung cancer
    Luo, Lianxiang
    Wu, Tong
    Ji, Miaorong
    Xiang, Jing
    Zou, Youwen
    Liao, Yinglin
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 133
  • [49] Metformin reduces PD-L1 on tumor cells and enhances the anti-tumor immune response generated by vaccine immunotherapy
    Munoz, Luis Enrique
    Huang, Lei
    Bommireddy, Ramireddy
    Sharma, Richa
    Monterroza, Lenore
    Guin, Rohini N.
    Samaranayake, Sarah G.
    Pack, Christopher D.
    Ramachandiran, Sampath
    Reddy, Shaker J. C.
    Shanmugam, Mala
    Selvaraj, Periasamy
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (11)
  • [50] Palmitoylation stabilizes PD-L1 to promote breast tumor growth
    Yang, Yi
    Hsu, Jung-Mao
    Sun, Linlin
    Chan, Li-Chuan
    Li, Chia-Wei
    Hsu, Jennifer L.
    Wei, Yongkun
    Xia, Weiya
    Hou, Junwei
    Qiu, Yufan
    Hung, Mien-Chie
    CELL RESEARCH, 2019, 29 (01) : 83 - 86
12345